NH
Nicholas Holowko UBS Latest Price Targets & Analyst Ratings
Main Sector
Financials
Ratings Past Year
31
Avg Return
Past Year
Past Year
0.87%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
27.3%
Neutral
72.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Financials
Healthcare
Financials
Banks - Regional
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $34 |
1%
upside
| 1 | – |
–
| 5 Nov ‘25 29 days ago |
|
|
|
Buy
Maintained
| $2,250 |
15%
upside
| 1 | -3.2% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Neutral
Maintained
| $11.50 |
10%
downside
| 1 | – |
–
| 5 Nov ‘25 29 days ago |
|
|
|
Buy
Maintained
| $105 |
23%
upside
| 1 | -2.3% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Neutral
Maintained
| $49 |
3%
downside
| 1 | -5.7% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Neutral
Maintained
| $95 |
1%
downside
| 1 | – |
–
| 5 Nov ‘25 29 days ago |
|
|
|
Buy
Maintained
| $120 |
30%
upside
| 1 | -6.7% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Neutral
Maintained
| $57 |
3%
upside
| 1 | – |
–
| 5 Nov ‘25 29 days ago |
|
|
|
Neutral
Maintained
| $115 |
6%
upside
| 1 | – |
–
| 28 Oct ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $50 |
7%
upside
| 1 | – |
–
| 28 Oct ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $127 |
8%
upside
| 1 | – |
–
| 24 Oct ‘25 1 month ago |
|